Cite
HARVARD Citation
Crabb, S. et al. (2021). Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID). Journal of clinical oncology. 39 (3), pp. 190-201. [Online].